1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Matthew Frank: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies Fludarabine, Cyclophosphamide, CD22 CAR - B-ALL, B-cell Non Hodgkin Lymphoma | Phase 1 | Completed | Matthew Frank | 52 | 2019-09-12 | 2026-03-30 |
Lymphoma, B-Cell (1)
Cyclophosphamide (1) · fludarabine (1)
United States (1)
K08CA248968 (1)